Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility Assessment of a Pharmacy-to-Dose Daptomycin Protocol: A Retrospective Cohort Study

NCT05224687 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT05224687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility Assessment of a Pharmacy-to-Dose Daptomycin Protocol: A Retrospective Cohort Study
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Unknown status
Start date
December 15, 2021
Completion date
December 15, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotics causing adverse effects in therapeutic use